Crescent Biopharma CBIO
NASDAQ CBIO
$14.76 +0.84 (+6.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Crescent Biopharma (CBIO) Return on Assets [ROA] (2014 - 2026)

Updated

Crescent Biopharma's Return on Assets [ROA] was -85.43% in Q2 2026, down 35.06 percentage points from -50.37% a year earlier and down 12.57 percentage points from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Crescent Biopharma came in at -111.59%, down 17.93 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for seven consecutive years, with a five-year change of -78.75 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -93.66% in FY2024 (-17.68 pp), -75.98% in FY2023 (-12.09 pp), -63.89% in FY2022 (-10.40 pp) and -53.48% in FY2021 (-20.65 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q1 2025.
  • Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of +12.33 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2025 (a gain of 160.26 percentage points); the worst was Q3 2024 (a drop of 131.91 percentage points).
  • Per Business Quant data, CBIO's Return on Assets [ROA] in the three quarters before Q2 2026 was -72.86% (Q1 2026), -73.51% (Q4 2025) and -37.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Crescent Biopharma 386.36 Mn -320.93 Mn - -85.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -85.43%
Mar 31, 2026 -72.86%
Dec 31, 2025 -73.51%
Sep 30, 2025 -37.84%
Jun 30, 2025 -50.37%
Mar 31, 2025 -141.62%
Dec 31, 2024 -147.54%
Sep 30, 2024 -198.10%
Jun 30, 2024 -133.44%
Mar 31, 2024 -93.75%
Dec 31, 2023 -74.91%
Sep 30, 2023 -66.19%
Jun 30, 2023 -57.19%
Mar 31, 2023 -70.23%
Dec 31, 2022 -86.64%
Sep 30, 2022 -89.03%
Jun 30, 2022 -85.56%
Mar 31, 2022 -72.59%
Dec 31, 2021 -62.71%
Sep 30, 2021 -53.00%
API Access

Crescent Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEY